Rising rates of antimicrobial resistance threaten the ability of clinicians to treat even the most basic infections. Evidence has demonstrated that hospital-based antibiotic stewardship programs (ASPs) significantly reduce hospital rates of antibiotic resistant infections however most existing ASPs fail to address the upstream causes of community exposure to antibiotic resistant bacteria caused by pharmaceutical pollution and the misuse of antibiotics outside the hospital. An estimate of 70% of overall tonnage of antimicrobial agents sold in the US are distributed for use in food-producing animals. Recent studies have proven that antibiotic waste from manufacturing sites doesn’t just pollute the environment, but is also a reservoir of resistant microbes. While isolating patients with resistant infections and maintaining a high level of hygiene are priorities for health professionals, there are additional opportunities for clinicians to broaden their antibiotic stewardship.
Driven by clinician leadership, Health Care Without Harm US and Europe are championing a comprehensive approach to antimicrobial stewardship through hospital policies and operations to curb pharmaceutical waste and reduce the purchase of meat raised with routine antibiotics. Speakers will detail strategies spearheaded by the US Clinician Champions in Comprehensive Antibiotic Stewardship (CCCAS) Collaborative and Health Care Without Harm Europe’s Safer Pharma campaign. This session will provide health professionals with practical tools, strategies, and case studies to tackle AMR in their daily practice as well as through institutional and international policy.